ABDUL RASHID MAKHDOMI
Allopathic & Osteopathic Physicians|Internal Medicine EASTON, PA NPI 1497718902
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine PA Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,847.21
- Category: General Payments
- Program years: PY2018–2021
- Record count: 64
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $141.79 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $141.79 | 8 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.78 | 1 |
| PFIZER INC. | $20.07 | 1 |
| Amarin Pharma Inc. | $19.63 | 1 |
| Acerta Pharma LLC | $16.65 | 1 |
| Janssen Pharmaceuticals, Inc | $15.90 | 1 |
| Kowa Pharmaceuticals America, Inc. | $14.78 | 1 |
| Abbott Laboratories | $13.36 | 1 |
| Lilly USA, LLC | $12.62 | 1 |
By program year
Records — PY2021 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 763547274 | Boehringer Ingelheim Pharmaceuticals, Inc. | $28.78 | 09/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 788316275 | Janssen Pharmaceuticals, Inc | $15.90 | 08/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 805524553 | Kowa Pharmaceuticals America, Inc. | $14.78 | 09/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 815299573 | Amarin Pharma Inc. | $19.63 | 08/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 818903593 | Lilly USA, LLC | $12.62 | 07/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 829337033 | AstraZeneca Pharmaceuticals LP | $16.65 | 08/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 833386779 | PFIZER INC. | $20.07 | 07/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 833836465 | Abbott Laboratories | $13.36 | 08/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.